Xu Xiaoyan

476 total citations
4 papers, 62 citations indexed

About

Xu Xiaoyan is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xu Xiaoyan has authored 4 papers receiving a total of 62 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 1 paper in Neurology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Xu Xiaoyan's work include Neuroblastoma Research and Treatments (1 paper), RNA modifications and cancer (1 paper) and Myasthenia Gravis and Thymoma (1 paper). Xu Xiaoyan is often cited by papers focused on Neuroblastoma Research and Treatments (1 paper), RNA modifications and cancer (1 paper) and Myasthenia Gravis and Thymoma (1 paper). Xu Xiaoyan collaborates with scholars based in China. Xu Xiaoyan's co-authors include Pu Xia, Jie Wu, Shumin Wang, Weiwei Lin, Xinxin Peng, Ge Jin, Hongmei Yu, Qi Li, Xiangdong Zhou and Zhaoting Meng and has published in prestigious journals such as Cell Death and Disease, Cells and Thoracic Cancer.

In The Last Decade

Xu Xiaoyan

4 papers receiving 62 citations

Peers

Xu Xiaoyan
Deborah Knoerzer United States
Ghassan Ghorayeb United States
Liselot Mus Belgium
Yan Ge China
Brittney Gordon United States
Ilona Dahmen Germany
William Yang United Kingdom
Xu Xiaoyan
Citations per year, relative to Xu Xiaoyan Xu Xiaoyan (= 1×) peers Kahira L. Saez‐Torres

Countries citing papers authored by Xu Xiaoyan

Since Specialization
Citations

This map shows the geographic impact of Xu Xiaoyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Xiaoyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Xiaoyan more than expected).

Fields of papers citing papers by Xu Xiaoyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Xiaoyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Xiaoyan. The network helps show where Xu Xiaoyan may publish in the future.

Co-authorship network of co-authors of Xu Xiaoyan

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Xiaoyan. A scholar is included among the top collaborators of Xu Xiaoyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Xiaoyan. Xu Xiaoyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Wang, Shumin, Jie Wu, Ge Jin, et al.. (2022). A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer. Cell Death and Disease. 13(4). 294–294. 28 indexed citations
2.
Xiaoyan, Xu, et al.. (2022). Metabolism in Cancer Stem Cells: Targets for Clinical Treatment. Cells. 11(23). 3790–3790. 12 indexed citations
3.
Meng, Zhaoting, et al.. (2018). EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes. Thoracic Cancer. 9(7). 885–891. 10 indexed citations
4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026